A 47-year-old woman with a BRCA2 mutation developed a 4-mm-sized invasive ductal carcinoma (IDC) that was estrogen receptor (ER)-positive and human epidermal growth factor receptor (HER2)-negative. Here, ERBB2 is linked to invasive ductal breast carcinoma.